A woman can know her skin for decades—the products it tolerates, where it gets oily, how it behaves in winter—and then find that somewhere in perimenopause or menopause the rules seem to change. Cheeks feel tight. Makeup sits differently. A forearm bruises after an ordinary bump. Skin that was reliably oily becomes dry and flaky, yet the T-zone still shines.
Those changes are not imaginary, and they are not all caused by one hormone. Menopause arrives in the same years as chronological ageing and decades of ultraviolet exposure. Genetics, smoking, climate, health conditions, medications and skin care also shape what we see. Estrogen is an important part of the biology, but it is not the sole controller of skin ageing.
Your skin did not suddenly become “bad.” The operating conditions changed. Understanding those conditions is more useful than blaming yourself—or buying every jar labelled “menopause.”
IN THIS ARTICLE
- Why estrogen matters to skin
- What actually happens to collagen
- Is the “30% collagen loss” statistic true?
- Why menopausal skin can become dry
- Why formerly oily skin can suddenly behave differently
- Skin thinning, fragility and bruising
- Wrinkles, crepiness and loss of firmness
- Menopause versus ageing and sun damage
- What MHT/HRT actually does to skin
- What you can realistically do
- When a skin change deserves medical attention
IN THIS ARTICLE
- Why estrogen matters to skin
- What actually happens to collagen
- Why menopausal skin can become dry
- Skin thinning, fragility and bruising
- Wrinkles, crepiness and loss of firmness
- Menopause versus ageing and sun damage
- What MHT/HRT actually does to skin
- What you can realistically do
- When a skin change deserves medical attention
- Sources and further reading
Why estrogen matters to skin
Skin is not a passive wrapper. It is a living organ made of interacting layers. The epidermis is the outer cellular layer. Its uppermost part, the stratum corneum, forms much of the barrier that slows water loss and keeps irritants and microbes out. Beneath it lies the dermis, a supportive layer containing blood vessels, nerves, hair follicles and an extracellular matrix rich in collagen, elastin and water-binding molecules.
Fibroblasts are key cells in that dermal workshop. They make and remodel collagen, elastin and other matrix components. Collagen provides tensile strength; elastin helps skin recoil after stretching. The matrix is continually maintained rather than poured once and left untouched: old proteins are broken down, new ones are synthesized, and the balance changes with age, UV exposure, inflammation and hormones.
Estrogen receptors are present in several skin cell types, including keratinocytes, fibroblasts, melanocytes and cells associated with blood vessels and hair follicles. Laboratory, observational and clinical research links estrogen signalling with collagen production and turnover, dermal thickness, elasticity, hydration, barrier function and wound healing. After menopause, lower estrogen exposure is therefore biologically relevant to skin. It does not follow that every dry patch or wrinkle is an estrogen symptom, or that replacing estrogen can reverse every change.
Perimenopause is also not a clean on/off switch. Ovarian hormone production can fluctuate before settling at lower postmenopausal levels, while skin is simultaneously accumulating another year of intrinsic ageing and environmental exposure. The result differs considerably among women and across body sites.
What actually happens to collagen
Most dermal collagen is type I, with type III contributing to a finer supporting network. Fibroblasts synthesize collagen precursors, enzymes help assemble strong fibres, and matrix metalloproteinases help break damaged collagen down. Healthy remodelling requires both construction and demolition to remain in balance.
Intrinsic ageing gradually reduces fibroblast activity and changes the organization and quality of the extracellular matrix. Collagen fibres become more fragmented; fibroblasts lose some of the mechanical tension that helps them function; new collagen production declines. Ultraviolet radiation adds a second pathway. Repeated UV exposure increases oxidative stress and collagen-degrading enzymes and produces the disorganized elastin and mottled pigment associated with photoageing.
Estrogen appears to interact with these processes. Lower estrogen signalling may reduce collagen synthesis and alter degradation, vascularity, hydration and wound repair. Studies comparing premenopausal and postmenopausal skin, and small trials of hormone therapy, support an effect. But collagen is difficult to measure, study methods vary, and menopause cannot be separated perfectly from age in every dataset.
Is the “30% collagen loss” statistic true?
You may have seen the claim that women lose about 30% of their skin collagen in the first five years after menopause, followed by roughly 2% a year. It is a widely repeated estimate, not a personal forecast.
The figure traces back largely to older, relatively small studies that assessed skin collagen in selected groups of women. Later reviews have repeated it because the overall direction is plausible and consistent with evidence of accelerated early postmenopausal change. It does not mean every woman loses exactly 30%, that the loss happens uniformly over the whole body, or that a mirror can distinguish menopause-related collagen change from sun damage, genetics and chronological ageing.
The sound conclusion is less dramatic but more defensible: collagen declines with age, and the loss of estrogen appears to accelerate aspects of that decline around menopause, particularly in the earlier postmenopausal years. The famous number describes a group estimate from a limited evidence base; it should not be used to predict an individual face.
Why menopausal skin can become dry
The stratum corneum is often explained as “bricks and mortar.” Flattened corneocytes are the bricks; a lipid mixture containing ceramides, cholesterol and fatty acids forms the mortar between them. Natural moisturizing factors inside the cells bind water. Together, this system limits transepidermal water loss (TEWL)—water that passively moves from inside the body through the epidermis and evaporates.
When the barrier is disrupted or its lipids are depleted, water escapes more readily and irritants enter more easily. Skin may feel tight, rough, flaky or stingy. Age-related changes in epidermal renewal and lipids, environmental dryness, hot water, harsh cleansers and overuse of exfoliating ingredients can all contribute. Estrogen-related changes in epidermal function, dermal glycosaminoglycans and water-binding capacity may contribute too. Sebaceous activity may decrease for some women, reducing the oily film that helps slow evaporation.
Hyaluronic acid is one of several glycosaminoglycans that bind water in skin. A topical hyaluronic-acid product can act as a humectant at the surface, but it is not the same as restoring the deeper extracellular matrix. And drinking more water is not equivalent to repairing the epidermal barrier. Adequate hydration matters for general health, but once a person is normally hydrated, another bottle of water does not replace missing ceramides or stop cleansing-related lipid loss.
Why formerly oily skin can suddenly behave differently
“Dry” and “oily” are convenient cosmetic labels, not fixed biological identities. Sebum output varies by body site and is influenced by age, androgens, products and climate. Barrier function also varies independently. That is how someone can have dry cheeks, flaky areas, an oily T-zone and acne at the same time.
A heavy acne cleanser used everywhere may worsen dry areas. Conversely, treating all skin as delicate and dry may feel occlusive on oilier areas. A more useful approach is to respond to what each area is doing now: gentle cleansing, less unnecessary exfoliation, and different textures where needed. Persistent adult acne, facial hair or an abrupt major change deserves its own assessment rather than being folded automatically into “menopause skin.”
Skin thinning, fragility and bruising
With age, the epidermis and dermis change, the junction between them becomes flatter, and collagen, elastin, small blood vessels and supporting tissue become more vulnerable. Lower estrogen may contribute to reduced dermal thickness and structural support. The backs of the hands, forearms and other sun-exposed areas often show the combined effects especially clearly: visible veins, easier tearing, slower healing and bruises after minor knocks.
Cumulative UV exposure is a major part of that picture. So are corticosteroid medicines, including prolonged use of potent topical steroids, and drugs that affect clotting such as anticoagulants and antiplatelet agents. Platelet disorders, liver disease, nutritional deficiencies and other medical conditions can also cause bruising.
Do not assume unexplained bruising is menopause. Arrange medical assessment if bruises are spontaneous, extensive, rapidly increasing, unusually large, accompanied by nose or gum bleeding, pinpoint red-purple spots, marked fatigue or illness, or began after a medication change.
Wrinkles, crepiness and loss of firmness
“Crepey skin” is a description, not a diagnosis. It usually refers to finely wrinkled, thin-looking skin that resembles crepe paper, often on the neck, upper arms, chest, hands or around the eyes. Its appearance reflects several layers at once: collagen and elastin quality, epidermal and dermal thickness, surface hydration, subcutaneous fat, muscle and bone structure, plus gravity and movement.
Menopause can be one contributor through changes in collagen, thickness and hydration. Intrinsic ageing changes cell turnover and matrix maintenance. Photoageing adds coarse wrinkles, uneven pigment, roughness and loss of elasticity. Weight change can alter the volume beneath skin. It is generally impossible to assign an individual wrinkle, jowl or patch of laxity specifically to estrogen loss.
Menopause versus ageing and sun damage
The timing is frustrating: hormonal change, chronological ageing and the visible bill for decades of sun exposure arrive together. Photoageing is often disproportionate on the face, upper chest, backs of the hands and forearms—the places most repeatedly exposed. Areas protected by clothing can look very different from nearby exposed skin of the same person.
UV radiation damages DNA, promotes pigment changes and accelerates breakdown of collagen and elastin. That is why sun protection still matters after menopause. It cannot erase exposure that has already occurred, but it reduces further damage and helps protect any gains from retinoids or procedures. Shade, clothing, hats and broad-spectrum sunscreen are complementary tools; sunscreen is not permission to stay in intense sun indefinitely.
What MHT/HRT actually does to skin
A 2023 systematic review and meta-analysis pooled 15 studies involving 1,589 women. Menopausal hormone therapy (MHT, also called HRT) was associated with improvements in measured skin elasticity, thickness and collagen content. The pooled change in dryness was not statistically significant. That distinction matters: “some measurements improved” is not the same as “MHT reliably moisturizes skin or removes wrinkles.”
The studies used different hormones, formulations, routes, doses, durations and measurement methods. Several were small or older, and the evidence does not tell us precisely which regimen would produce a meaningful visible benefit for a particular woman. More recent reviews continue to find biologically plausible and sometimes measurable effects while emphasizing the same need for better trials.
Systemic MHT may benefit some characteristics of postmenopausal skin. It should not be started solely as a cosmetic anti-ageing or wrinkle treatment. The established decision is based on menopausal symptoms, health history, benefits, risks and preferences—not on using hormones as skin care. Maple’s Canadian guide to hormones and MHT explains systemic and local estrogen, uterine protection and prescribing context.
Should I put estrogen cream on my face?
This question has moved quickly from research literature into social feeds and commercial skin-care marketing. The premise is not absurd: estrogen receptors exist in skin, and topical estradiol, estriol and related approaches have been studied. Some small and often older studies report changes in collagen, thickness, elasticity or clinical appearance. A growing research and commercial field is exploring whether low-dose, skin-specific formulations can deliver useful local effects.
That interest does not yet establish routine facial estrogen as a proven, standardized menopause skin treatment. Studies have used different compounds and concentrations, often in small samples and for limited periods. Important questions remain about formulation, dose, systemic absorption, long-term exposure, appropriate patient selection and whether measured changes produce benefits women can actually see and value.
Prescription vaginal estrogen products were formulated and studied for genitourinary syndrome of menopause (GSM), not for do-it-yourself facial use. “Topical” also does not automatically mean “stays only where it is placed”; absorption depends on the molecule, vehicle, dose, skin site and barrier. Repurposing a prescription cream makes the dose and exposure less predictable and leaves the face exposed to ingredients designed for a different tissue and indication.
Pigmentation deserves explicit attention. Estrogen can influence melanocyte activity, and hormonal states and exposures are associated with melasma. That does not prove a facial estrogen product will darken every user’s skin. Evidence linking topical facial or vaginal estrogen to melasma remains sparse, and chronic facial-use effects are not well characterized. Still, altered or increased pigmentation is a plausible concern that should not be dismissed—particularly for women with a history of melasma and for women with skin of colour, for whom pigmentary changes can be especially consequential.
Maple Menopause’s position for now: interesting and promising enough to watch, but not established enough for us to tell you to put prescription estrogen on your face. If you are considering a prescribed hormonal facial treatment, discuss the actual formulation, evidence, pigmentation history, absorption and monitoring with a qualified clinician or dermatologist rather than experimenting with vaginal estrogen cream.
What you can realistically do
The most useful routine is usually less theatrical than the marketing. Cleanse gently, especially if skin feels tight after washing. Lukewarm water and a fragrance-free cleanser used where needed may be better tolerated than hot water, scrubs and repeated foaming cleansers. Introduce active ingredients one at a time so you can identify irritation rather than trying to repair a suddenly burning face after a complete routine overhaul.
Moisturizers work through different ingredient roles:
- Humectants, such as glycerin and hyaluronic acid, attract and hold water.
- Emollients smooth gaps between surface cells and improve feel.
- Occlusives, including petrolatum, reduce water evaporation.
- Barrier lipids, such as ceramides, can support the stratum corneum’s lipid structure.
A thin “hydrating serum” may add a humectant but provide too little emollient or occlusive support for genuinely dry skin. Applying a moisturizer to slightly damp skin and choosing a cream or ointment rather than a light lotion can make a meaningful difference. Very occlusive products may not suit every acne-prone area, which is another reason to treat regions according to their current behaviour.
Broad-spectrum sunscreen, protective clothing and shade are the foundation for limiting additional photoageing. Topical retinoids have evidence for improving photoaged skin and stimulating dermal remodelling, but they can irritate dry or reactive skin and require a gradual, individualized approach. Procedures can address selected concerns, but outcomes, cost, downtime and risk—especially pigment change—depend on the procedure and skin type. These treatment comparisons belong in a dedicated skin-care guide rather than being compressed into a shopping list here.
What about collagen supplements?
The evidence has become less tidy, not more. A 2025 systematic review and meta-analysis included 23 randomized trials with 1,474 participants. When all studies were pooled, collagen supplements appeared to improve hydration, elasticity and wrinkles. Those benefits were not demonstrated when the analysis was restricted to non-industry-funded studies or higher-quality evidence.
Other recent meta-analyses have reported improvements, but they also describe heterogeneous products, doses, outcome measures and substantial risk-of-bias concerns. This does not prove collagen supplements never help. It means the apparent average benefit may be smaller and less certain than marketing suggests, and confidence is weakened by study quality and industry influence.
A fair conclusion is: possible benefit, uncertain magnitude. A supplement should not displace sunscreen, barrier care, adequate overall nutrition or assessment of a real skin disorder. Maple’s evidence-first supplement guide explains how to judge claims, Canadian product licensing and conflicts of interest.
Do you need “menopause skincare”?
Changing skin needs during menopause are real. A menopause label does not itself prove superior efficacy. A well-formulated, tolerable, reasonably priced moisturizer does not become less suitable because its jar says nothing about hormones; a beautifully branded “menopause” cream is not automatically useless either.
Judge products by formulation, ingredients, evidence, tolerability, packaging and price. Phytoestrogens and other estrogen-related approaches are interesting research areas, but ingredient plausibility is not the same as a clinically meaningful result from the finished product. No one needs an entirely menopause-labelled routine to take menopausal skin seriously.
When a skin change deserves medical attention
Menopause can alter the background conditions of skin, but it should not become a label pasted over every new finding. Dermatologic disease, thyroid disease, nutritional problems, medication effects, systemic illness and extensive UV damage can overlap with midlife.
Arrange assessment for a new or changing mole or lesion, an “ugly duckling” spot that looks unlike the others, a sore that does not heal, unexplained extensive bruising, rapidly worsening or widespread symptoms, signs of infection, or severe and persistent changes that do not respond to basic care. Sudden bruising with other bleeding, or a very unwell feeling, needs prompt attention. The American Academy of Dermatology recommends regular self-checks and evaluation of suspicious changes rather than waiting for them to become dramatic.
Itching, crawling, burning and stinging can have their own dermatologic, neurologic and systemic explanations. They are covered separately in Maple Menopause’s guide to itchy, crawly and burning skin sensations. Hair changes are addressed in why menopause hair may thin, shed or dry out. Vulvar and vaginal dryness belongs in the distinct clinical context of genitourinary syndrome of menopause. When dryness affects the eyes, mouth, skin and hair together, the broader menopause dryness guide helps separate overlapping symptoms. For a gentle routine rather than more skin biology, see K-Beauty After 45.
Skin change in menopause is real, but it is not a single condition with a single fix. The sensible goal is not to make skin behave exactly as it did at 30. It is to understand what changed, protect the barrier and sun-exposed tissue, use treatments with realistic expectations, and investigate changes that do not fit the ordinary pattern.
Sources and further reading
- Skin Rejuvenation in Women Using Menopausal Hormone Therapy: A Systematic Review and Meta-Analysis (2023).
- Estrogens and Aging Skin, Dermato-Endocrinology.
- Menopause, Skin and Common Dermatoses, Part 2: Skin Disorders, Clinical and Experimental Dermatology.
- Endocrine Controls of Skin Aging, Endocrine Reviews (2025).
- Effects of Collagen Supplements on Skin Aging: A Systematic Review and Meta-Analysis of Randomized Controlled Trials, The American Journal of Medicine (2025).
- Update on Melasma—Part I: Pathogenesis.
- Does Hormone Replacement Therapy Influence Melasma Development? A Review of the Evidence and Management Guidelines (2026).
- American Academy of Dermatology: Dermatologists’ tips for relieving dry skin.
- American Academy of Dermatology: How to check your skin.
Educational information only. Maple Menopause does not provide medical advice, diagnosis or treatment. Last evidence review: September 2026.